Clinical Trials Logo

Memory Complaint clinical trials

View clinical trials related to Memory Complaint.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05806697 Not yet recruiting - Alzheimer Disease Clinical Trials

Investigation of AlzHeimer's Predictors in Subjective Memory Complainers - Extension Study

INSIGHT-2
Start date: April 17, 2023
Phase: N/A
Study type: Interventional

A regional, single-center, prospective, observational academic cohort will follow subjects who previously participated in the INSIGHT study and who agree an extension of their follow-up in the INSIGHT-2 research for additional 5-6 years. An annual multimodal evaluation (cognitive, oculomotor, biological and neuroimaging) will be proposed in order to describe the natural history of preclinical Alzheimer's disease (AD). The primary endpoint is the conversion to the symptomatic stage in subjects at risk, identified by positive amyloid staining (A+) on florbetapir positron emission tomography (PET) imaging. The size of the cohort is estimated to around 240 participants (61 A+ subjects) among the 318 participants included in the main cohort (88 A+ subjects). The follow-up in the INSIGHT-2 cohort will be lightened compared to that of the main cohort with an annual frequency of visits rather than a six-monthly one.